Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
ClinicalTrials.gov study NCT00535873. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
ClinicalTrials.gov study NCT02970318. IPD Sharing: YES. Countries: 25. Publications: 2.
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
ClinicalTrials.gov study NCT01723839. IPD Sharing: Not stated. Countries: 1. Publications: 63.
A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
ClinicalTrials.gov study NCT03406156. IPD Sharing: YES. Countries: 1. Publications: 0.
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00267059. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
ClinicalTrials.gov study NCT00074282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
ClinicalTrials.gov study NCT03400176. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
ClinicalTrials.gov study NCT02268851. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL
ClinicalTrials.gov study NCT01203930. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02005471. IPD Sharing: YES. Countries: 20. Publications: 7.
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00545714. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
ClinicalTrials.gov study NCT01752426. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab in Pretreated Elderly or Unfit B-CLL Patients
ClinicalTrials.gov study NCT01576588. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lym
ClinicalTrials.gov study NCT03462719. IPD Sharing: Not stated. Countries: 14. Publications: 3.
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00448019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
ClinicalTrials.gov study NCT04560322. IPD Sharing: YES. Countries: 1. Publications: 1.
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02301156. IPD Sharing: NO. Countries: 2. Publications: 1.
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
ClinicalTrials.gov study NCT00086580. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
ClinicalTrials.gov study NCT01520922. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01178086. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.